These innovative medications , Tirzepatide , represent a remarkable advancement in treating obesity and conceivably related ailments . They are grouped as GLP-1 receptor agonists , signifying they to replicate the endogenous GLP-1 hormone , enhancing insulin secretion and suppressing appetite . D